Articles

Qiming Star | Changsen Pharma Raises Hundreds of Millions of Yuan in Series B+ Funding to Accelerate Clinical Research and Global Expansion of Core Pipeline

Qiming Star | Changsen Pharma Raises Hundreds of Millions of Yuan in Series B+ Funding to Accelerate Clinical Research and Global Expansion of Core Pipeline

Changsen Pharma is dedicated to independently developing first-in-class, best-in-class innovative drugs with global intellectual property rights to address unmet clinical needs.